Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

623 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The eosinophilia-myalgia syndrome--guidelines for patient care.
Hertzman PA, Kaufman LD, Love LA, Mease PJ, Philen RM, Pincus T, Rosenberg NL, Silver R, Varga J, Clauw DJ. Hertzman PA, et al. Among authors: mease pj. J Rheumatol. 1995 Jan;22(1):161-3. J Rheumatol. 1995. PMID: 7699664 Review. No abstract available.
Efficacy of milnacipran in patients with fibromyalgia.
Gendreau RM, Thorn MD, Gendreau JF, Kranzler JD, Ribeiro S, Gracely RH, Williams DA, Mease PJ, McLean SA, Clauw DJ. Gendreau RM, et al. Among authors: mease pj. J Rheumatol. 2005 Oct;32(10):1975-85. J Rheumatol. 2005. PMID: 16206355 Clinical Trial.
Outcome measures in psoriatic arthritis.
Gladman DD, Mease PJ, Krueger G, van der Heidje DM, Antoni C, Helliwell PS, Kavanaugh AF, Nash P, Ritchlin CT, Strand CV, Taylor W. Gladman DD, et al. Among authors: mease pj. J Rheumatol. 2005 Nov;32(11):2262-9. J Rheumatol. 2005. PMID: 16265714
Fibromyalgia syndrome.
Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, Simon LS, Strand CV, Bramson C, Martin S, Wright TM, Littman B, Wernicke JF, Gendreau RM, Crofford LJ. Mease PJ, et al. J Rheumatol. 2005 Nov;32(11):2270-7. J Rheumatol. 2005. PMID: 16265715
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.
Lassere MN, Johnson KR, Boers M, Tugwell P, Brooks P, Simon L, Strand V, Conaghan PG, Ostergaard M, Maksymowych WP, Landewe R, Bresnihan B, Tak PP, Wakefield R, Mease P, Bingham CO 3rd, Hughes M, Altman D, Buyse M, Galbraith S, Wells G. Lassere MN, et al. J Rheumatol. 2007 Mar;34(3):607-15. J Rheumatol. 2007. PMID: 17343307
Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein.
Keeling SO, Landewe R, van der Heijde D, Bathon J, Boers M, Garnero P, Geusens P, El-Gabalawy H, Inman RD, Kraus VB, Kvien TK, Mease PJ, Ostergaard M, Ritchlin C, Syversen SW, Maksymowych WP. Keeling SO, et al. Among authors: mease pj. J Rheumatol. 2007 Mar;34(3):623-33. J Rheumatol. 2007. PMID: 17343310 Review.
Assessing single joints in arthritis clinical trials.
Giles JT, Mease P, Boers M, Bresnihan B, Conaghan PG, Heald A, Maksymowych WP, Maillefert JF, Simon L, Tsuji W, Wakefield R, Woodworth T, Schumacher HR, Bingham CO 3rd. Giles JT, et al. J Rheumatol. 2007 Mar;34(3):641-7. J Rheumatol. 2007. PMID: 17343312
623 results